Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank

INTRODUCTION: Intravenous augmentation therapy with purified intravenous alpha-1 antitrypsin replaces the deficient protein and is the only currently approved treatment for alpha-1 antitrypsin deficiency (AATD) related lung disease. While augmentation therapy has been available for more than 20 year...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tonelli, Adriano R, Rouhani, Farshid, Li, Ning, Schreck, Pam, Brantly, Mark L
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2009
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2802045/
https://ncbi.nlm.nih.gov/pubmed/20054436
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky